BioWorld

March 23, 1992

View Archived Issues

THREE PATENTS COVER NEUROGEN TECHNOLOGY

Read More

APPOINTMENTS AND ADVANCEMENTS

Read More

MABS MAKER FILES TO SELL 2.3 MILLION SHARES

Read More

DEPRENYL STOCK STAGES A REBOUND

Read More

ORAL DELIVERY DEVELOPER RAISES $17.8M

Read More

GENZYME HORMONE DESIGNATED ORPHAN

Read More

OVERFED IPO MARKET CATCHES ITS BREATH

Read More